Methods of Esthetic Assessment after Adjuvant Whole-Breast Radiotherapy in Breast Cancer Patients: Evaluation of the BCCT.core Software and Patients' and Physicians' Assessment from the Randomized IMRT-MC2 Trial.
Tobias ForsterClara KöhlerMelissa DornMatthias Felix HäfnerNathalie AriansLaila KönigSemi Ben HarrabiIngmar SchlamppEva MeixnerVanessa HeinrichNicola WeidnerMichael GolattaAndré HennigsJörg HeilHolger HofDavid KrugJürgen DebusJuliane Hörner-RieberPublished in: Cancers (2022)
The present analysis compares the esthetics assessment by the BCCT.core software in relation to patients' and physicians' ratings, based on the IMRT-MC2 trial. Within this trial, breast cancer patients received breast-conserving surgery (BCS) and adjuvant radiotherapy. At the baseline, 6 weeks, and 2 years after radiotherapy, photos of the breasts were assessed by the software and patients' and physicians' assessments were performed. Agreement rates of the assessments and their correlation with breast asymmetry indices were evaluated. The assessments of the software and the physicians were significantly correlated with asymmetry indices. Before and 6 weeks after radiotherapy, the patients' self-assessment was only correlated with the lower breast contour (LBC) and upward nipple retraction (UNR), while after 2 years, there was also a correlation with other indices. Only a slight agreement between the BCCT.core software and the physicians' or patients' assessment was seen, while a moderate and substantial agreement was detected between the physicians' and the patients' assessment after 6 weeks and 2 years, respectively. The BCCT.core software is a reliable tool to measure asymmetries, but may not sufficiently evaluate the esthetic outcome as perceived by patients. It may be more appropriate for a long-term follow-up, when symmetry appears to increase in importance.
Keyphrases
- end stage renal disease
- primary care
- ejection fraction
- newly diagnosed
- chronic kidney disease
- early stage
- prognostic factors
- peritoneal dialysis
- clinical trial
- physical activity
- squamous cell carcinoma
- randomized controlled trial
- study protocol
- mental health
- phase iii
- patient reported outcomes
- lymph node
- phase ii
- atrial fibrillation
- open label
- high intensity
- patient reported
- coronary artery bypass
- placebo controlled